Therapeutic Area Market Research Reports & Industry Analysis

The Therapeutic Area Market refers to a specific category of diseases or conditions for which there are known medical treatments or promising treatments in development. It is a way to classify drugs without reference to the type of therapy, form of action, or the company that makes it, but instead to look at the disease it treats.

Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.

Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.

...Show More ...Show Less


Therapeutic Area Industry Research & Market Reports

  • Human Papillomavirus (HPV) Testing

    ... 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$919.4 Million ... Read More

  • Artificial Joints

    ... CAGR of 4.4% over the analysis period 2024-2030. Cemented Joints, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$21.2 Billion by the end of the analysis ... Read More

  • Breast Cancer Screening

    ... at a CAGR of 5.1% over the analysis period 2024-2030. Imaging Test, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$4.8 Billion by the end of ... Read More

  • Cervical Pillows

    ... CAGR of 5.4% over the analysis period 2024-2030. Standard Cervical Pillows, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$2.8 Billion by the end of the ... Read More

  • Phototherapy Equipment

    ... CAGR of 3.5% over the analysis period 2024-2030. LED Phototherapy Equipment, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$238.9 Million by the end of the ... Read More

  • Pulmonary / Respiratory Drug Delivery

    ... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Metered Dose Inhalers, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$35.9 ... Read More

  • Spinal Trauma Devices

    ... at a CAGR of 5.6% over the analysis period 2024-2030. Internal Fixation Devices, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$4.9 Billion by the end ... Read More

  • Brain Implants

    ... CAGR of 10.6% over the analysis period 2024-2030. Deep Brain Stimulation, one of the segments analyzed in the report, is expected to record a 11.2% CAGR and reach US$8.7 Billion by the end of the ... Read More

  • Intraoral Scanners

    ... CAGR of 7.2% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$507.3 Million by the end of the analysis period. ... Read More

  • Male Hypogonadism

    ... CAGR of 5.1% over the analysis period 2024-2030. Testosterone Replacement Therapy, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$3.5 Billion by the end of the ... Read More

  • Carotid Stents

    ... CAGR of 8.6% over the analysis period 2024-2030. Balloon Expandable Stents, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$4.3 Billion by the end of the ... Read More

  • Smoking Cessation and Nicotine De-Addiction Products

    ... reach US$54.9 Billion by 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. E-cigarettes, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$43.5 ... Read More

  • Postpartum Depression - Market Insights, Epidemiology, and Market Forecast - 2034

    ... of ~USD 25 Million in 2023. Among the seven major countries, the Postpartum Depression diagnosed prevalent cases were ~1,310,000, in 2023. In EU4 and the UK, the total Postpartum Depression diagnosed prevalent cases in Females ... Read More

  • Health Impact Report - All Industries Edition

    ... government tariffs and trade policy uncertainty on investments in employee wellbeing and mental health technologies. This report analyses thousands of sustainability disclosures from 20 leading entities in the industry, including Johnson & Johnson, UnitedHealth Group, ... Read More

  • B-cell Lymphoma- Pipeline Insight, 2025

    ... also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage B-cell Lymphoma: Understanding B-cell Lymphoma: Overview ... Read More

  • Postpartum Depression - Pipeline Insight, 2025

    ... It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Postpartum Depression: Understanding Postpartum Depression: ... Read More

  • Metastatic Colorectal Cancer - Pipeline Insight, 2025

    ... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Metastatic Colorectal Cancer: ... Read More

  • Microbiome Disease- Pipeline Insight, 2025

    ... also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Microbiome Disease: Understanding Microbiome Disease: Overview ... Read More

  • Serotonin Reuptake Inhibitor (SRI) - Pipeline Insight, 2025

    ... of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the ... Read More

  • Bone Graft Substitutes

    ... at a CAGR of 6.6% over the analysis period 2024-2030. Allograft, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$2.5 Billion by the end of the ... Read More

  • 2025 Global Fertility Tourism Market Industry (2031 Outlook)

    ... a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market trends, technology analysis, ... Read More

  • 2025 Global Gene Therapy For Heart Failure Market Industry (2031 Outlook)

    ... size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market ... Read More

  • 2025 Global Gene Therapy For Ovarian Cancer Market Industry (2031 Outlook)

    ... size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market ... Read More

  • Dental Fluoride Treatment

    ... at a CAGR of 5.2% over the analysis period 2024-2030. Toothpaste, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$4.2 Billion by the end of the ... Read More

  • Intracranial Pressure (ICP) Monitoring Devices

    ... Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Invasive, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$2.4 Billion by ... Read More

Cookie Settings